Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.48 |
| ▸ | TP53 | P04637 | 4/20 | 0.48 |
| ▸ | NPC1 | O15118 | 7/20 | 0.47 |
| ▸ | RAB9A | P51151 | 7/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.46 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.45 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.45 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17329248 | 1.00 | KMT2A (0.52) | KMT2AMEN1SMN1; SMN2TP53NPC1 | |
| SCHEMBL17329238 | 0.88 | GPR17 (0.50) | KMT2AMEN1SMN1; SMN2TP53NPC1 | |
| SCHEMBL17329247 | 0.88 | TP53 (0.54) | KMT2AMEN1SMN1; SMN2TP53NPC1 | |
| SCHEMBL17329246 | 0.88 | TP53 (0.54) | KMT2AMEN1SMN1; SMN2TP53NPC1 | |
| SCHEMBL17329237 | 0.88 | GPR17 (0.50) | KMT2AMEN1SMN1; SMN2TP53NPC1 | |
| SCHEMBL17329259 | 0.87 | MEN1 (0.56) | KMT2AMEN1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL17329258 | 0.87 | MEN1 (0.56) | KMT2AMEN1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL17329183 | 0.87 | PRMT1 (0.52) | KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL17329184 | 0.87 | PRMT1 (0.52) | KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL18709244 | 0.83 | MEN1 (0.47) | KMT2AMEN1NPC1RAB9ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9630939-B2 | Derivative of homoserine lactone, and preparation method and use thereof | INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) | 2017-04-25 | — | — | US | claimed |
| US-20150368217-A1 | Derivative of Homoserine Lactone, and Preparation Method and Use Thereof | INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) | 2015-12-24 | — | — | US | claimed |
| EP-2955174-A1 | DERIVATIVE OF HOMOSERINE LACTONE, AND PREPARATION METHOD AND USE THEREOF | Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China (CN) | 2015-12-16 | — | — | EP | claimed |
| US-9630939-B2 | Derivative of homoserine lactone, and preparation method and use thereof | INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) | 2017-04-25 | — | — | US | disclosed |
| US-20150368217-A1 | Derivative of Homoserine Lactone, and Preparation Method and Use Thereof | INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) | 2015-12-24 | — | — | US | disclosed |
| EP-2955174-A1 | DERIVATIVE OF HOMOSERINE LACTONE, AND PREPARATION METHOD AND USE THEREOF | Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China (CN) | 2015-12-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368217-A1 | Derivative of Homoserine Lactone, and Preparation Method and Use Thereof | LSS, HES1, SOS1 | KMT2A 3880/4885MEN1 589/4885SMN1; SMN2 4662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.